Literature DB >> 24710939

Influences of IL-6R antibody on PMMA bone cement-mediated expression of OPG and RANKL in synovial fibroblasts.

Ke Tao1, Hui Zeng2, De-Ming Xiao1, Ao Xiong1, Jian Weng1, Bin Kang1.   

Abstract

Effect of interleukin-6 receptor (IL-6R) antibody on polymethyl methacrylate (PMMA) bone cement-mediated expression of osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand (RANKL) in synovial fibroblasts was investigated. Synovial tissue obtained from total knee arthroplasty was digested and cultured. Inverted microscope was employed to observe the synovial cells and immunocytochemistry (SABC method) staining was used to identify synovial fibroblasts. This experiment was divided into three groups according to different culture media: PMMA group (75 μg/mL PMMA bone cement particles), IL-6R antibody group (10 ng/mL IL-6R antibody+75 μg/mL PMMA bone cement particles), and control group (no IL-6R antibody or PMMA bone cement particles). Influence of IL-6R antibody and PMMA on proliferation of synovial fibroblasts was measured by cell counting kit-8 (CCK-8). ELISA method was used to measure OPG and RANKL levels in culture solution. Fluorescence quantitative real-time PCR (FQ-PCR) was used to detect the expression of OPG and RANKL mRNA. After three consecutive passages, more than 95% of the primary synovial cells became long spindle fibroblast-like cells. SABC staining results showed that the fibroblast-like cells were negative for anti-CD68 antibody and positive for anti-vimentin antibody, with brown madder stained. CCK-8 test demonstrated that the absorbance (A) value at 450 nm was significantly lower in IL-6R antibody group than in PMMA group and control group (P<0.01), but there was no statistically significant difference in A value at 450 nm between the control group and PMMA group (P>0.05). Results of ELISA indicated that the expression of OPG was significantly higher in IL-6R antibody group than in PMMA group and control group (P<0.01). The expression of RANKL was inhibited (P<0.05), and the ratio of OPG/RANKL was significantly increased in IL-6R antibody group as compared with PMMA group and control group. There was no significant difference in the expression of OPG between control group and PMMA group (P>0.05), but the expression of RANKL was higher in PMMA group than in control group (P<0.05), and there was a significant difference in the ratio of OPG/RANKL between them (P<0.05). Results of FQ-PCR revealed the expression of RANKL mRNA was significantly inhibited (P<0.01) and the expression of OPG mRNA was significantly increased (P<0.01) in IL-6R antibody group as compared with PMMA group and control group. The expression of RANKL mRNA was higher in PMMA group than in control group (P<0.05), but the expression of OPG mRNA had no significant difference between them (P>0.05). IL-6R antibody could significantly increase the expression of OPG, but inhibit the expression of RANKL, which might provide a theoretical basis of molecular biology for the prevention and treatment of aseptic loosening of prosthesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710939     DOI: 10.1007/s11596-014-1265-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  23 in total

Review 1.  Immunotherapeutic implication of IL-6 blockade.

Authors:  Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Immunotherapy       Date:  2012-01       Impact factor: 4.196

Review 2.  Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.

Authors:  Iris Navarro-Millán; Jasvinder A Singh; Jeffrey R Curtis
Journal:  Clin Ther       Date:  2012-03-22       Impact factor: 3.393

Review 3.  Review of periprosthetic osteolysis in total joint arthroplasty: an emphasis on host factors and future directions.

Authors:  Ryan T Beck; Kenneth D Illingworth; Khaled J Saleh
Journal:  J Orthop Res       Date:  2011-09-15       Impact factor: 3.494

4.  The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis.

Authors:  Tamas Koreny; Miklós Tunyogi-Csapó; Istvan Gál; Csaba Vermes; Joshua J Jacobs; Tibor T Glant
Journal:  Arthritis Rheum       Date:  2006-10

5.  Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

Authors:  Mark C Genovese; James D McKay; Evgeny L Nasonov; Eduardo F Mysler; Nilzio A da Silva; Emma Alecock; Thasia Woodworth; Juan J Gomez-Reino
Journal:  Arthritis Rheum       Date:  2008-10

6.  Patient and health professional views on rehabilitation practices and outcomes following total hip and knee arthroplasty for osteoarthritis:a focus group study.

Authors:  Marie D Westby; Catherine L Backman
Journal:  BMC Health Serv Res       Date:  2010-05-11       Impact factor: 2.655

7.  Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Authors:  Josef S Smolen; Andre Beaulieu; Andrea Rubbert-Roth; Cesar Ramos-Remus; Josef Rovensky; Emma Alecock; Thasia Woodworth; Rieke Alten
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

Review 8.  Canonical and non-canonical pathways of osteoclast formation.

Authors:  H J Knowles; N A Athanasou
Journal:  Histol Histopathol       Date:  2009-03       Impact factor: 2.303

9.  The central role of wear debris in periprosthetic osteolysis.

Authors:  P Edward Purdue; Panagiotis Koulouvaris; Bryan J Nestor; Thomas P Sculco
Journal:  HSS J       Date:  2006-09

10.  Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.

Authors:  Stephanie Hennigan; Arthur Kavanaugh
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

View more
  3 in total

1.  Distinct expression of chemokine-like factor 1 in synovium of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

Authors:  Ke Tao; Xu Tang; Bin Wang; Ru-Jun Li; Bao-Qing Zhang; Jian-Hao Lin; Hu Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-02-03

Review 2.  The Effect of RANKL/OPG Balance on Reducing Implant Complications.

Authors:  Elizabeth R Kapasa; Peter V Giannoudis; Xiaodong Jia; Paul V Hatton; Xuebin B Yang
Journal:  J Funct Biomater       Date:  2017-09-22

3.  A protocol for the culture and isolation of murine synovial fibroblasts.

Authors:  Jinjun Zhao; Qingqing Ouyang; Ziyou Hu; Qin Huang; Jing Wu; Ran Wang; Min Yang
Journal:  Biomed Rep       Date:  2016-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.